| | | ENILCONAZOLE
CAS:35554-44-0
Trade Name: 1-[2-(2,4-dichlorophenyl)-2-prop-2-enoxyethyl]imidazole
Formula: C14H14Cl2N2O
APS35554440
297.18
1H-Imidazole, 1-[2-(2,4-dichlorophenyl)-2-(2-propenyloxy)ethyl]- (9CI), Bromazil, (RS)-1-[2-(Allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole, (R,S)-1-[2-(2,4-Dichlorophenyl)-2-(2-propenyloxy)ethyl]-1H-imidazole, CGA 41333, NuZone, 1-[(2 ENNIATIN B
CAS:917-13-5
Trade Name: (3S,6R,9S,12R,15S,18R)-4,10,16-trimethyl-3,6,9,12,15,18-hexa(propan-2-yl)-1,7,13-trioxa-4,10,16-tria
Formula: C33H57N3O9
ACM917135
639.82 ENNIATIN B1
CAS:19914-20-6
Trade Name: (3S,6R,9S,12R,15S,18R)-3-[(2S)-Butan-2-yl]-4,10,16-trimethyl-6,9,12,15,18-penta(propan-2-yl)-1,7,13-
Formula: C34H59N3O9
ACM19914206
653.85 ENNIATIN COMPLEX
CAS:11113-62-5
Trade Name: (3S,9S,15S)-4,10,16-trimethyl-3,6,9,12,15,18-hexa(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacycloocta
Formula: C33H57N3O9
ACM11113625
639.8
Enniatin, Enniatins, CID3084092, 11113-62-5 ENO1 Protein, Human, Recombinant (His)
RHC-ENZY-2352
49.3 kDa (predicted); 47 kDa (reducing conditions)
PPH, NNE, MPB1, HEL-S-17, enolase 1, (+¦), enolase 1, (alpha), ENO1L1 ENOLICAM
CAS:59755-82-7
Trade Name: 7-chloro-N-(3,4-dichlorophenyl)-5-hydroxy-1,1-dioxo-2,3-dihydro-1$l^{6}-benzothiepine-4-carboxamide
Formula: C17H12Cl3NO4S
ACM59755827
432.71
Enolicam, UNII-TEA6PI0H6H, 59755-82-7, Enolicamum, Enolicam [INN], AC1NUR2Y, Enolicamum [INN-Latin], TEA6PI0H6H, AC1L1BS4, AC1O3H8G, SCHEMBL35455, CHEMBL2110813, SCHEMBL10892917, HE358115, (4E)-7-chloro-4-[(3,4-dichloroanilino)-hydroxymethy ENOXAPARIN SODIUM
CAS:9041-08-1
APS9041081
Monoparin, Kabi 2165, Alfa 87-163, RO 14, Viatromb, Lipo-Hepin, Lioton 1000, Fragmin IV, Alfa 87-81, Bemiparin sodium, Badyket, Lipo-Hepinette, Semuloparin sodium, WY 90493RD, OP 2000, Logiparin, Longheparin, Ardeparin sodium, RP 54563, Sod ENOXOLONE
CAS:471-53-4
Trade Name: (2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7
Formula: C30H46O4
APS471534
470.68
Glycyrrhetin, STX 352, alpha-Glycyrrhetinic acid, 18beta-Glycyrrhetinic acid, GM 1658, Arthrodont, Subglycyrrhelinic acid, 18beta-Glycyrrhetic acid, Uralenic acid (7CI), NSC 35347, Olean-12-en-30-oic acid, 3beta-hydroxy-11-oxo- (8CI),Enoxol Enoxolone 100 -¦g/mL in Acetonitrile
CAS:471-53-4
Trade Name: (2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7
Formula: C30H46O4
APS471534A
470.68
Glycyrrhetin, NSC 35347, alpha-Glycyrrhetinic acid, 18beta-Glycyrrhetic acid, GM 1658, Subglycyrrhelinic acid, Uralenic acid (7CI), PO 12, STX 352, Arthrodont, Glycyrrhetic acid, 18beta-Glycyrrhetinic acid, Olean-12-en-30-oic acid, 3beta-hy ENPP1 Protein, Human, Recombinant (C-His)
RHC-ENZY-1763
96.5 kDa (predicted). Due to glycosylation, the pr
PDNP1, PCA1ARHR2, PCA1, PC1, NPPS, NPPase, NPP1, M6S1NPP1, M6S1, Ly-41 Antigen, ENPP1, E-NPP 1 ENPP1 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-ENZY-1408
98.29 kDa (predicted). Due to glycosylation, the p
PDNP1, PCA1ARHR2, PCA1, PC1, NPPS, NPPase, NPP1, M6S1NPP1, M6S1, Ly-41 Antigen, ENPP1, E-NPP 1 ENPP1 Protein, Human, Recombinant (N-His)
RHC-ENZY-2016
96.5 kDa (predicted). Due to glycosylation, the pr
PDNP1, PCA1ARHR2, PCA1, PC1, NPPS, NPPase, NPP1, M6S1NPP1, M6S1, Ly-41 Antigen, ENPP1, E-NPP 1 ENPP1 Protein, Mouse, Recombinant (His)
RHC-ENZY-2042
95.99 kDa (predicted). Due to glycosylation, the p
PDNP1, PCA1ARHR2, PCA1, PC1, NPPS, NPPase, NPP1, M6S1NPP1, M6S1, Ly-41 Antigen, ENPP1, E-NPP 1 ENPP2 Protein, Human, Recombinant (His)
RHC-ENZY-1793
96 kDa (predicted); 120-130 kDa (reducing conditio
PDNP2, PD-I+¦, PD-IALPHA, NPP2, LysoPLD, ectonucleotide pyrophosphatase/phosphodiesterase 2, AUTOTAXIN, ATX-X, ATX ENPP2 Protein, Mouse, Recombinant (His)
RHC-ENZY-2338
96 kDa (predicted); 55-75 kDa (reducing condition,
Pdnp2, PD-I+¦, PD-Ialpha, Npps2, lysoPLD, E-NPP 2, ectonucleotide pyrophosphatase/phosphodiesterase 2, ATX ENPP3 Protein, Canine, Recombinant (His)
RHC-ENZY-1770
96.19 kDa (predicted). Due to glycosylation, the p
PDNP3, PD-I+¦, PD-Ibeta, NPPase, NPP3, gp130RB13-6, ENPP3, E-NPP 3, CD203c, B10 ENPP3 Protein, Human, Recombinant (aa 48-157, His & Avi)
RHC-ENZY-1570
17.21 kDa (predicted). Due to glycosylation, the p
PDNP3, PD-I+¦, PD-Ibeta, NPPase, NPP3, gp130RB13-6, ENPP3, E-NPP 3, CD203c, B10 ENPP3 Protein, Human, Recombinant (aa 558-875, His)
RHC-ENZY-2259
39.06 kDa (predicted). Due to glycosylation, the p
PDNP3, PD-I+¦, PD-Ibeta, NPPase, NPP3, gp130RB13-6, ENPP3, E-NPP 3, CD203c, B10 ENPP3 Protein, Human, Recombinant (His & Avi)
RHC-ENZY-1416
99.97 kDa (predicted). Due to glycosylation, the p
PDNP3, PD-I+¦, PD-Ibeta, NPPase, NPP3, gp130RB13-6, ENPP3, E-NPP 3, CD203c, B10 ENPP3 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-ENZY-2217
99.97 kDa (predicted). Due to glycosylation, the p
PDNP3, PD-I+¦, PD-Ibeta, NPPase, NPP3, gp130RB13-6, ENPP3, E-NPP 3, CD203c, B10 ENROFLOXACIN D5 HYDROCHLORIDE
Trade Name: 1-cyclopropyl-6-fluoro-4-oxo-7-[4-(1,1,2,2,2-pentadeuterioethyl)piperazin-1-yl]quinoline-3-carboxyli
Formula: C192H5H17FN3O3.ClH
APS007814
400.89
Enrofloxacin D5 Hydrochloride (ethyl d5), 1-Cyclopropyl-7-[4-(ethyl-1,1,2,2,2-d5)-1-piperazinyl]-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid hydrochloride Ensitrelvir
CAS:2647530-73-0
Trade Name: 6-[(6-chloro-2-methylindazol-5-yl)amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[(2,4,5-trifluoro
Formula: C22H17ClF3N9O2
ACM2647530730
531.88
6-[(6-Chloro-2-methylindazol-5-yl)amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[(2,4,5-trifluorophenyl)methyl]-1,3,5-triazine-2,4-dione ENT NAXAGOLIDE HYDROCHLORIDE
CAS:100935-99-7
Trade Name: (4aR,10bR)-4-propyl-2,3,4a,5,6,10b-hexahydrobenzo[h][1,4]benzoxazin-9-ol;hydrochloride
Formula: C15H22ClNO2
ACM100935997-1
283.79
(4aS-trans)-3,4,4a,5,6,10b-Hexahydro-4-propyl-2H-naphth[1,2-b]-1,4-oxazin-9-ol Hydrochloride; (-)-Propyl-9-hydroxynaphthoxazine Hydrochloride;(-)-PHNO ENT NAXAGOLIDE HYDROCHLORIDE
CAS:100935-99-7
Trade Name: (4aR,10bR)-4-propyl-2,3,4a,5,6,10b-hexahydrobenzo[h][1,4]benzoxazin-9-ol;hydrochloride
Formula: C15H22ClNO2
ACM100935997
283.79
(4aS-trans)-3,4,4a,5,6,10b-Hexahydro-4-propyl-2H-naphth[1,2-b]-1,4-oxazin-9-ol Hydrochloride; (-)-Propyl-9-hydroxynaphthoxazine Hydrochloride;(-)-PHNO ent-11+¦-Hydroxy-15-oxokaur-16-en-19-oic acid
CAS:57719-81-0
Trade Name: (1R,4S,5R,9R,10S,11S,13S)-11-hydroxy-5,9-dimethyl-14-methylidene-15-oxotetracyclo[11.2.1.01,10.04,9]
Formula: C20H28O4
BBC57719810
332.44
(4alpha,11beta)-11-Hydroxy-15-oxokaur-16-en-18-oic acid ENT-11,16-EPOXY-15-HYDROXYKAURAN-19-OIC ACID
CAS:77658-46-9
Trade Name: (1R,4S,5R,9R,10S,11S,13R,14R,16S)-16-hydroxy-5,9,13-trimethyl-12-oxapentacyclo[11.2.1.111,14.01,10.0
Formula: C20H30O4
ACM77658469
334.5 ENT-11ALPHA-HYDROXYABIETA-8(14),13(15)-DIEN-16,12ALPHA-OLIDE
CAS:130466-20-5
Trade Name: (4aR,10aS,11R,11aR,11bR)-11-hydroxy-4,4,8,11b-tetramethyl-2,3,4a,5,6,10a,11,11a-octahydro-1H-naphtho
Formula: C20H28O3
ACM130466205
316.44 ENT-11BETA-HYDROXYATIS-16-ENE-3,14-DIONE
CAS:1092103-22-4
Trade Name: (1S,4S,9R,10S,11R,12R)-11-hydroxy-5,5,9-trimethyl-16-methylidenetetracyclo[10.2.2.01,10.04,9]hexadec
Formula: C20H28O3
ACM1092103224
316.4 ENT-14,15-DINOR-13-OXOLABDA-8(17),11-DIEN-18-OIC ACID
CAS:875585-30-1
Trade Name: (1S,4aR,5R,8aS)-1,4a-dimethyl-6-methylidene-5-[(E)-3-oxobut-1-enyl]-3,4,5,7,8,8a-hexahydro-2H-naphth
Formula: C18H26O3
ACM875585301
290.4 ENT-14,15-DINOR-13-OXOLABDA-8(17),11-DIEN-18-OIC ACID
CAS:875585-30-1
Trade Name: (1S,4aR,5R,8aS)-1,4a-dimethyl-6-methylidene-5-[(E)-3-oxobut-1-enyl]-3,4,5,7,8,8a-hexahydro-2H-naphth
Formula: C18H26O3
ACM875585301
290.4 ENT-14,16-EPOXY-8-PIMARENE-3,15-DIOL
CAS:1188281-98-2
Trade Name: (1R,3aR,5aS,7R,9aR,11aR)-6,6,9a,11a-tetramethyl-2,3a,4,5,5a,7,8,9,10,11-decahydro-1H-naphtho[1,2-g][
Formula: C20H32O3
ACM1188281982
320.5 Ent-16-kaurene-3+¦,15+¦,18-triol
CAS:921211-29-2
Trade Name: (1R,4S,5S,6R,9S,10S,13R,15S)-5-(hydroxymethyl)-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.01,10.04
Formula: C20H32O3
BBC921211292
320.47
(3alpha,4beta,15alpha)-Kaur-16-ene-3,15,18-triol ENT-16-KAURENE-3BETA,15BETA,18-TRIOL
CAS:921211-29-2
Trade Name: (1R,4S,5S,6R,9S,10S,13R,15S)-5-(hydroxymethyl)-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.01,10.04
Formula: C20H32O3
ACM921211292
320.5 Ent-3+¦-hydroxykaur-16-en-19-oic acid
CAS:66556-91-0
Trade Name: (1S,4S,5S,6R,9S,10R,13R)-6-hydroxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.01,10.04,9]hexadecan
Formula: C20H30O3
BBC66556910
318.45
(3alpha,4alpha)-3-Hydroxykaur-16-en-18-oic acid ENT-3BETA,18-DIHYDROXYLABDA-8(17),13E-DIEN-15-OIC ACID
CAS:99624-39-2
Trade Name: (E)-5-[(1R,4aS,5S,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-3,4,4a,6,7,8-hexah
Formula: C20H32O4
ACM99624392
336.46 ENT-6,11-DIHYDROXY-15-OXO-16-KAUREN-19-OIC ACID BETA-D-GLUCOPYRANOSYL ESTER
CAS:81263-97-0
Trade Name: [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1S,3R,4S,5R,9S,10S,11S,13S)-3,11-dih
Formula: C26H38O10
ACM81263970
510.6 ENT-6,9-DIHYDROXY-15-OXO-16-KAUREN-19-OIC ACID
CAS:81264-00-8
Trade Name: (1S,3R,4S,5R,9R,10R,13R)-3,10-dihydroxy-5,9-dimethyl-14-methylidene-15-oxotetracyclo[11.2.1.01,10.04
Formula: C20H28O5
ACM81264008
348.4 ENT-7ALPHA,9-DIHYDROXY-15-OXOKAUR-16-EN-19,6BET-OLIDE
CAS:59885-89-1
Trade Name: (1R,2R,5R,8S,9R,10R,13R,17S)-2,9-dihydroxy-1,13-dimethyl-6-methylidene-11-oxapentacyclo[8.6.1.15,8.0
Formula: C20H26O5
ACM59885891
346.42 ENT-9-HYDROXY-15-OXO-16-KAUREN-19-OIC ACID BETA-D-GLUCOPYRANOSYL ESTER
CAS:81263-96-9
Trade Name: [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1R,4S,5R,9R,10R,13R)-10-hydroxy-5,9-
Formula: C26H38O9
ACM81263969
494.6 ENT-9-HYDROXY-15-OXO-19-KAURANOIC ACID
CAS:77658-45-8
Trade Name: (1R,4S,5R,9R,10R,13R,14R)-10-hydroxy-5,9,14-trimethyl-15-oxotetracyclo[11.2.1.01,10.04,9]hexadecane-
Formula: C20H30O4
ACM77658458
334.5 ENT-ATISANE-3BETA,16ALPHA,17-TRIOL
CAS:115783-44-3
Trade Name: (1S,4S,6R,9S,10R,12S,13S)-13-(hydroxymethyl)-5,5,9-trimethyltetracyclo[10.2.2.01,10.04,9]hexadecane-
Formula: C20H34O3
ACM115783443
322.5 ENT-DEFLUORO FOSAPREPITANT DIMEGLUMINE
Formula: C23H23F6N4O6P-+2 C7H17NO5
APB06334
986.84
(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentaol hemi((3-(((2S,3R)-2-((S)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-phenylmorpholino)methyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonate) ENT-EMTRICITABINE
CAS:137530-41-7
Trade Name: 4-amino-5-fluoro-1-[(2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
Formula: C8H10FN3O3S
APS137530417
247.25
(+)-2'-Deoxy-3'-thia-5-fluorocytidine, 4-Amino-5-fluoro-1-[(2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one,2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-[(2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, (2'S,5'R)-Emtricitabine, 1 ENT-FOSAPREPITANT DIMEGLUMINE
Formula: C23H22F7N4O6P-+2 C7H17NO5
APB06336
1004.83
(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentaol hemi((3-(((2S,3R)-2-((S)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)methyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonate) ENT-GALANTHAMINE
CAS:60384-53-4
Formula: C17H21NO3
ACM60384534
287.35
(4aR,6S,8aR)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofurol[3a,3,2,-ef][2]benzazepin-6-ol; (+)-Galanthamine; ENT-KAURANE-16BETA,19,20-TRIOL
CAS:167898-32-0
Trade Name: (1S,4R,5R,9R,10R,13R,14R)-5,9-bis(hydroxymethyl)-5,14-dimethyltetracyclo[11.2.1.01,10.04,9]hexadecan
Formula: C20H34O3
ACM167898320
322.48 ENT-KAURANE-3,16,17-TRIOL
CAS:130855-22-0
Trade Name: (1S,4S,9S,10R,13R,14S)-14-(hydroxymethyl)-5,5,9-trimethyltetracyclo[11.2.1.01,10.04,9]hexadecane-6,1
Formula: C20H34O3
ACM130855220
322.5 ENT-LABDA-8(17),13Z-DIENE-15,16,19-TRIOL 19-O-GLUCOSIDE
CAS:1245636-01-4
Trade Name: (2R,3R,4S,5S,6R)-2-[[(1R,4aS,5R,8aS)-5-[(Z)-5-hydroxy-3-(hydroxymethyl)pent-3-enyl]-1,4a-dimethyl-6-
Formula: C26H44O8
ACM1245636014
484.6 ENT-OSELTAMIVIR PHOSPHATE
CAS:1035895-89-6
Trade Name: ethyl (3S,4S,5R)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate;phosphoric acid
Formula: C16H28N2O4.H3O4P
APS1035895896
410.40
Ethyl (3S,4S,5R)-4-acetamido-5-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1-carboxylate phosphate salt, [3S-(3+¦,4+¦,5+¦)]-4-(Acetylamino)-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid ethyl ester phosphate salt, Ethyl (3S,4S,5R)-5-am ENT-TADALAFIL
CAS:629652-72-8
Formula: C22H19N3O4
ACM629652728
389.40
(6S,12aS)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione; L-Tadalafil; L-Tildenafil; ENT-TADALAFIL
CAS:629652-72-8
Trade Name: (2S,8S)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.0^{3,8}.0^{11,16}]heptadeca-
Formula: C22H19N3O4
APS629652728
389.40
(6S,12aS)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methylpyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione, Tadalafil Imp. B (EP), (6S,12aS)-6-(1,3-Benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b ENT-TADALAFIL-D3
Formula: C22H16D3N3O4
ACMA00057097
392.42
(6S,12aS)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-(methyl-d3)-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione; L-Tadalafil-d3; L-Tildenafil-d3 ENTECAVIR FOR SYSTEM SUITABILITY
CAS:209216-23-9
Trade Name: 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1H-purin-6-one;hydrate
Formula: C12H15N5O3.H2O
APS209216239A
295.29
Entecavir monohydrate,6H-Purin-6-one, 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-, hydrate (1:1), 6H-Purin-6-one, 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopenty ENTECAVIR IMPURITY F
CAS:649761-24-0
Trade Name: 2-amino-9-[(1S,3R,4S)-4-[dimethyl(phenyl)silyl]-2-methylidene-3-(phenylmethoxymethyl)cyclopentyl]-1H
Formula: C27H31N5O2Si
APS649761240
485.65
2-Amino-9-[(1S,3R,4S)-3-[(benzyloxy)methyl]-4-[dimethyl(phenyl)silyl]-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one, Entecavir Monohydrate Imp. F (EP), 6H-Purin-6-one, 2-amino-9-[(1S,3R,4S)-4-(dimethylphenylsilyl)-2-methylene-3-[(phe ENTECAVIR MONOHYDRATE
CAS:209216-23-9
Trade Name: 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1H-purin-6-one;hydrate
Formula: C12H15N5O3.H2O
APS209216239
295.29
6H-Purin-6-one, 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-, hydrate (1:1), Entecavir monohydrate, 6H-Purin-6-one, 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopent ENTEROBACTIN
CAS:28384-96-5
Trade Name: N-[(3S,7S,11S)-7,11-bis[(2,3-dihydroxybenzoyl)amino]-2,6,10-trioxo-1,5,9-trioxacyclododec-3-yl]-2,3-
Formula: C30H27N3O15
ACM28384965
669.55
N-[(3S,7S,11S)-7,11-bis[(2,3-dihydroxybenzoyl)amino]-2,6,10-trioxo-1,5,9-trioxacyclododec-3-yl]-2,3-dihydroxybenzamide; Enterobactin; ENTEROCIN
CAS:59678-46-5
Trade Name: Enterocin
Formula: C22H20O10
ACM59678465
444.3882
ENTEROCIN;(3R,8R)-7+¦-Benzoyl-4,4a,5,6,7,7a-hexahydro-4a+¦,6+¦,7a+¦,8-tetrahydroxy-5+¦-(4-methoxy-2-oxo-2H-pyran-6-yl)-3+¦,6-methanocyclopenta[c]pyran-1(3H)-one;Vulgamycin;3,6-Methanocyclopenta(C)pyran-1(3H)-one, 7-benzoylhexahydro-4A,6,7A,8-tetr ENTERODIOL
CAS:80226-00-2
Trade Name: (2R,3R)-2,3-bis[(3-hydroxyphenyl)methyl]butane-1,4-diol
Formula: C18H22O4
ACM80226002
302.36
(-)-ENTERODIOL;ENTERODIOL;4,4',9,9'-TETRAHYDROXYLIGNAN;3,3'-[2,3-BIS(HYDROXYMETHYL)BUTANE-1,4-DIYL]DIPHENOL;ENTERODIOL, >95% (HPLC);ENTERODIOL hplc;2,3-Bis(3-hydroxybenzyl)-1,4-butanediol;2,3-Bis[(3-hydroxyphenyl)methyl]-1,4-butanediol Enterokinase/EK Protein, Bovine, Recombinant
RHC-ENZY-1287
26.1 kDa (predicted); 45 kDa (reducing condition,
EK, Enterokinase, PRSS7, Enteropeptidase, EC 3.4.21.9, Serine protease 7, ENTK, MGC133046. ENTPD5 Protein, Mouse, Recombinant (His)
RHC-ENZY-1974
46.6 kDa (predicted); 45 kDa (reducing conditions)
Pcph, NTPDase-5, NTPDase5, mNTPase, ER-UDPase, ectonucleoside triphosphate diphosphohydrolase 5, Cd39l4, AI987697, AI196558 ENVIOMYCIN
CAS:33103-22-9
Trade Name: 3,6-diamino-N-[(6Z)-3-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-6-[(carbamoylamino)methylidene]-9,1
Formula: C25H43N13O10
ACM33103229
685.696
Enviomycin;1,4,7,10,13-Pentaazacyclohexadecane, cyclic peptide deriv.;enviomucin;Tuberactinomycin N (8CI, 9CI);Viomycin, 1-[(3R,4R)-4-hydroxy-3,6-diaminohexanoic acid]-6-[L-2-(2-amino-1,4,5,6-tetrahydro-4-pyrimidinyl)glycine]-, (R)-;N2-[(4R Environmental Cal Standard A (Primary): Ag, Al, As, Ba, Be, Cd, Co, Cr, Cu, Mn, Mo, Ni, Pb, Sb, Se, Sr, Ti, Tl, U, V, Zn @ 10; Ca, Fe, K, Mg, Na @ 1000 -¦g/mL in 5% HNO3, tr. HF, tr. Tartaric Acid
APS007827 Environmental ICV Std A (Second Source): Ag, Al, As, Ba, Be, Cd, Co, Cr, Cu, Mn, Mo, Ni, Pb, Sb, Se, Sr, Th, Tl, U, V, Zn @ 10; Ca, Fe, K, Mg, Na @ 1000 -¦g/mL in 5% HNO3, tr. HF, tr. Tartaric Acid
APS007829 EOS-d9 (d18:1-d9/32:0/18:2)
CAS:2692624-26-1
Formula: C68H120D9NO5
ACM2692624261
1049.80
32-(((2(S),3(R),E)-1,3-dihydroxyoctadec-4-en-2-yl-15,15,16,16,17,17,18,18,18-d9)amino)-32-oxodotriacontyl (9(Z),12Z)-octadeca-9,12-dienoate; N-(32-linoleoyloxy-dotriacontanoyl)-Sphingosine-d9 EOSIN DIACETATE
CAS:7284-92-6
Trade Name: (6-acetyloxy-2,4,5,7-tetrabromo-3-oxospiro[2-benzofuran-1,9-xanthene]-3-yl) acetate
Formula: C24H12Br4O7
ACM7284926
731.96
Eosin diacetate, AC1NQBOD, 45244_FLUKA, 45244_SIGMA, AKOS015916563, I14-49633, (6-acetyloxy-2,4,5,7-tetrabromo-3-oxospiro[2-benzofuran-1,9-xanthene]-3-yl) acetate, 7284-92-6 EOSIN Y DISODIUM SALT, DYE CONTENT 85%, INDICATOR
CAS:17372-87-1
Trade Name: disodium;2-(2,4,5,7-tetrabromo-3-oxido-6-oxoxanthen-9-yl)benzoate;
Formula: C20H6Br4Na2O5;
ACM17372871
691.859g/mol
Eosine YB; Phlox Red Toner X-1354; MCULE-3311428648; Spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one, 2',4',5',7'-tetrabromo-3',6'-dihydroxy-, sodium salt (1:2); CHEBI:52053; I14-18436; MFCD00036189; Eosine J; 7549-EP2277567A1; Certiqual Eo EOSIN Y DISODIUM SALT, DYE CONTENT 85%, INDICATOR
CAS:17372-87-1
Trade Name: disodium;2-(2,4,5,7-tetrabromo-3-oxido-6-oxoxanthen-9-yl)benzoate;
Formula: C20H6Br4Na2O5;
ACM17372871
691.859g/mol
Eosine YB; Phlox Red Toner X-1354; MCULE-3311428648; Spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one, 2',4',5',7'-tetrabromo-3',6'-dihydroxy-, sodium salt (1:2); CHEBI:52053; I14-18436; MFCD00036189; Eosine J; 7549-EP2277567A1; Certiqual Eo EOSIN Y DISODIUM SALT, DYE CONTENT 85%, INDICATOR
CAS:17372-87-1
Trade Name: disodium;2-(2,4,5,7-tetrabromo-3-oxido-6-oxoxanthen-9-yl)benzoate;
Formula: C20H6Br4Na2O5;
ACM17372871-1
691.859g/mol
Eosine YB; Phlox Red Toner X-1354; MCULE-3311428648; Spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one, 2',4',5',7'-tetrabromo-3',6'-dihydroxy-, sodium salt (1:2); CHEBI:52053; I14-18436; MFCD00036189; Eosine J; 7549-EP2277567A1; Certiqual Eo EPA ETHANOLAMIDE-D4
CAS:946524-41-0
Trade Name: (5Z,8Z,11Z,14Z,17Z)-N-(1,1,2,2-tetradeuterio-2-hydroxyethyl)icosa-5,8,11,14,17-pentaenamide
Formula: C22H31D4NO2
ACM946524410
349.50
Eicosapentaenoyl ethanolamide-d4; EPEA-d4 EPA FREE ACID
CAS:10417-94-4
Trade Name: (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoic acid
Formula: C20H30O2
ACM10417944-1
302.46
Eicosapentaenoic acid; Eicosa-5Z,8Z,11Z,14Z,17Z-pentaenoic acid (20:5, n-3) EPA Method 200.8: 10 mg/L Al, As, Be, Cd, Co, Cr, Mn, Mo, Ni, Pb, Sb, Se, Tl, Th, U, V
APS007848 EPA Method 200.8: SS-10 mg/L Al, As, Be, Cd, Co, Cr, Mn, Mo, Ni, Pb, Sb, Se, Tl, Th, U, V. Made fro
APS007853 EPA Method 541 UCMR 4 Surrogate 1-butanol d10 1000 -¦g/mL in Methanol
CAS:34193-38-9
Trade Name: 1,1,1,2,2,3,3,4,4-nonadeuterio-4-deuteriooxybutane
Formula: C42H10O
APS34193389
84.18
Decadeutero-1-butanol, 1-Butanol-d10, 1-Butanol D10, Butyl-d9 alcohol-d (8CI), Butanol-d10,1-Butan-1,1,2,2,3,3,4,4,4-d9-ol-d (9CI), Perdeutero-1-butanol EPA Method 552.3 2-Bromobutanoic Acid 10000 -¦g/mL in Methyl tert-butyl ether
CAS:80-58-0
Trade Name: 2-Bromobutanoic acid
Formula: C4H7BrO2
APS80580
167.00
(-¦)-2-Bromobutanoic acid, (-¦)-+¦-Bromobutanoic acid, (RS)-2-Bromobutyric acid,Butanoic acid, 2-bromo-, Butyric acid, 2-bromo- (6CI,7CI,8CI), NSC 8024, DL-+¦-Bromobutyric acid, +¦-Bromobutyric acid, DL-2-Bromo-n-butyric acid, 2-Bromobutanoic ac EpCAM/TROP1 Protein, Cynomolgus/Rhesus macaque, Recombinant
RHC-CART-0169
27.38 kDa (predicted). Due to glycosylation, the p
TROP1, TACSTD1, TACST-1, MOC31, MK1, MIC18, KSA, HNPCC8, gp40, ESA, EpCAM, EGP40, EGP314, EGP-2, EGP, DIAR5, CD326, ACSTD1 EpCAM/TROP1 Protein, Cynomolgus/Rhesus macaque, Recombinant (His)
RHC-CART-0127
28.5 kDa (predicted). Due to glycosylation, the pr
TROP1, TACSTD1, TACST-1, MOC31, MK1, MIC18, KSA, HNPCC8, gp40, ESA, EpCAM, EGP40, EGP314, EGP-2, EGP, DIAR5, CD326, ACSTD1 EpCAM/TROP1 Protein, Human, Recombinant (aa 24-265, hFc)
RHC-CART-0035
54.2 kDa (predicted). Due to glycosylation, the pr
TROP1, TACSTD1, TACST-1, MOC31, MK1, MIC18, KSA, HNPCC8, gp40, ESA, EpCAM, EGP40, EGP314, EGP-2, EGP, DIAR5, CD326, ACSTD1 EpCAM/TROP1 Protein, Human, Recombinant (aa 24-265, His & Avi), Biotinylated
RHC-CART-0112
30.1 kDa (predicted). Due to glycosylation, the pr
TROP1, TACSTD1, TACST-1, MOC31, MK1, MIC18, KSA, HNPCC8, gp40, ESA, EpCAM, EGP40, EGP314, EGP-2, EGP, DIAR5, CD326, ACSTD1 EpCAM/TROP1 Protein, Human, Recombinant (aa 24-265, His)
RHC-CART-0076
28.2 kDa (predicted). Due to glycosylation, the pr
TROP1, TACSTD1, TACST-1, MOC31, MK1, MIC18, KSA, HNPCC8, gp40, ESA, EpCAM, EGP40, EGP314, EGP-2, EGP, DIAR5, CD326, ACSTD1 EpCAM/TROP1 Protein, Human, Recombinant (hFc & Avi), Biotinylated
RHC-CART-0045
56 kDa (predicted)
TROP-1, TROP1, TACSTD1, MK-1, MIC18, M4S1, KSA, KS1/4, HNPCC8, ESA, epithelial cell adhesion molecule, EGP40, EGP314, EGP-2, DIAR5 EpCAM/TROP1 Protein, Human, Recombinant (hFc)
RHC-CART-0147
54 kDa (predicted); 65-70 kDa (reducing condition,
TROP-1, TROP1, TACSTD1, MK-1, MIC18, M4S1, KSA, KS1/4, HNPCC8, ESA, epithelial cell adhesion molecule, EGP40, EGP314, EGP-2, DIAR5 EpCAM/TROP1 Protein, Human, Recombinant (hFc), Biotinylated
RHC-CART-0020
54.1 kDa (predicted)
TROP-1, TROP1, TACSTD1, MK-1, MIC18, M4S1, KSA, KS1/4, HNPCC8, ESA, epithelial cell adhesion molecule, EGP40, EGP314, EGP-2, DIAR5 EpCAM/TROP1 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CART-0049
30.7 kDa (predicted)
TROP-1, TROP1, TACSTD1, MK-1, MIC18, M4S1, KSA, KS1/4, HNPCC8, ESA, epithelial cell adhesion molecule, EGP40, EGP314, EGP-2, DIAR5 EpCAM/TROP1 Protein, Human, Recombinant (His)
RHC-CART-0011
28.84 kDa (predicted); 36.5 kDa (reducing conditio
TROP-1, TROP1, TACSTD1, MK-1, MIC18, M4S1, KSA, KS1/4, HNPCC8, ESA, epithelial cell adhesion molecule, EGP40, EGP314, EGP-2, DIAR5 EpCAM/TROP1 Protein, Human, Recombinant (His), Biotinylated
RHC-CART-0204
29 kDa (predicted)
TROP-1, TROP1, TACSTD1, MK-1, MIC18, M4S1, KSA, KS1/4, HNPCC8, ESA, epithelial cell adhesion molecule, EGP40, EGP314, EGP-2, DIAR5 EpCAM/TROP1 Protein, Human, Recombinant (mFc)
RHC-CART-0110
53.81 kDa (predicted); 59.50 kDa (reducing conditi
TROP-1, TROP1, TACSTD1, MK-1, MIC18, M4S1, KSA, KS1/4, HNPCC8, ESA, epithelial cell adhesion molecule, EGP40, EGP314, EGP-2, DIAR5 EpCAM/TROP1 Protein, Mouse, Recombinant (hFc)
RHC-CART-0039
60-80 kDa (reducing condition)
TROP1, TACSTD1, TACST-1, MOC31, EpCAM, EGP40, EGP314, EGP-2, CD326, ACSTD1, 323/A3, 17-1A EpCAM/TROP1 Protein, Mouse, Recombinant (His)
RHC-CART-0047
29.1 kDa (predicted); 37 kDa (reducing condition,
TROP1, Tacstd1, Tacsd1, Ly74, gp40, GA733-2, epithelial cell adhesion molecule, EpCAM1, Ep-CAM, Egp314, EGP-2, EGP, CD326 |
